Author | Karen Singer


Early Palliative Care Improves QOL for Lung and GI Cancer Patients

December 04, 2017

ByKaren Singer

The early integration of oncology and palliative care enhanced coping strategies and improved QOL for patients newly diagnosed with incurable lung or GI cancer.

FDA Approves Adjuvant Therapy for High-Risk Renal Cell Carcinoma

November 17, 2017

ByKaren Singer

The FDA has approved a new indication for sunitinib (Sutent) to include the adjuvant treatment of renal cell carcinoma in patients at high risk of disease recurrence following nephrectomy.

Proton Therapy in Hodgkin Lymphoma Yields Favorable Acute Toxicity Profile

October 19, 2017

ByKaren Singer

A new study found that Hodgkin lymphoma patients treated with consolidative proton therapy after chemotherapy had “excellent” early relapse-free survival rates and no early grade 3 radiation-related toxicities.